Reversible MRI findings in a case of acute intermittent porphyria with a novel mutation in the porphobilinogen deaminase gene

Blood Cells Mol Dis. 2017 Mar:63:21-24. doi: 10.1016/j.bcmd.2016.12.005. Epub 2016 Dec 18.

Abstract

Acute intermittent porphyria (AIP) is an autosomal dominant disorder caused by a partial deficiency of porphobilinogen deaminase (PBGD), the third enzyme in the of heme biosynthetic pathway. It can affect the autonomic, peripheral, and central nervous system. Posterior reversible encephalopathy syndrome is a clinicoradiological entity characterized by headache, seizures, altered consciousness, and visual disorder associated with potentially reversible neuroradiological abnormalities predominantly in the parieto-occipital lobes. Establishing accurate diagnoses of the patient and asymptomatic family members with AIP involves identifying the PBGD enzyme mutations directly. In this study, we report a 28-year-old woman with acute intermittent porphyria who presented with radiological manifestations suggestive of posterior reversible encephalopathy syndrome, she had a novel PBGD frame shift mutation, base 875 and 876 have been deleted resulting in glutamine to a stop codon (Gln292fs), in a Chinese family.

Keywords: Acute porphyria; Gene mutation; Posterior reversible encephalopathy syndrome.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Asian People
  • Codon, Terminator
  • Diagnosis, Differential
  • Female
  • Frameshift Mutation*
  • Humans
  • Hydroxymethylbilane Synthase / genetics*
  • Magnetic Resonance Imaging
  • Porphyria, Acute Intermittent / diagnostic imaging
  • Porphyria, Acute Intermittent / genetics*
  • Posterior Leukoencephalopathy Syndrome / diagnosis
  • Posterior Leukoencephalopathy Syndrome / pathology

Substances

  • Codon, Terminator
  • Hydroxymethylbilane Synthase